The studies have demonstrated the highest concentrations of FABP3 in AD patients in comparison to other neurodegenerative disorders, such as Creutzfeldt–Jakob Disease (CJD), Parkinson’s Disease (PD) or Dementia with Levy Body(DLB) [29,31,37,38]. This evidence concerns the gene FABP3 and Lewy body dementia.